Product Introduction:
Ziten M Tablet combines Teneligliptin 20 mg, a DPP-4 inhibitor, with Metformin 500 mg, a biguanide, offering a dual mechanism to control blood sugar. Teneligliptin increases insulin secretion and decreases glucagon levels, while Metformin reduces hepatic glucose production and improves insulin sensitivity.
Uses:
-
Management of type 2 diabetes mellitus
-
For patients with inadequate glycemic control on Metformin or Teneligliptin monotherapy
Benefits:
-
Improves glycemic control through complementary actions
-
Helps reduce both fasting and postprandial blood glucose
-
Low risk of hypoglycemia compared to sulfonylureas
Composition:
-
Teneligliptin 20 mg
-
Metformin 500 mg
Side Effects:
-
Nausea
-
Diarrhea
-
Abdominal discomfort
-
Headache
-
Rare risk of lactic acidosis (due to Metformin)
Safety Advice:
-
Take with meals to reduce gastrointestinal side effects
-
Monitor blood sugar and kidney function regularly
-
Avoid alcohol during treatment
-
Inform your doctor if pregnant or breastfeeding
-
Use caution in patients with kidney or liver impairment
